Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Greg Lucier: Life after Life Tech
In a single decade, Greg Lucier, 49, transformed the relatively small firm Invitrogen into the international behemoth Life Technologies. Now that Thermo Fisher Scientific has completed its acquisition of Life Tech, Lucier says he may try “to serve in some appointed or possibly even elected capacity.” (For more on Greg Lucier, click here.) Would you vote for Lucier?